Bronchoprovocation testing in asthma

Effect on exhaled monoxides

Jigme M. Sethi, Anna M. White, Sanjay A. Patel, Jeannine V. DiNella, William Calhoun, Augustine M K Choi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Exhaled carbon monoxide and nitric oxide reflect allergic inflammation in asthma and have clinical utility for monitoring disease severity. The effects of allergen challenge and of inflammatory versus non-inflammatory bronchoconstrictive stimuli on the exhalation kinetics of these gases are unclear. The aim of this study is to compare and contrast the effects of methacholine and allergen challenges on the exhaled levels of carbon monoxide and nitric oxide in a cohort of adult subjects with atopic asthma. Eight subjects underwent inhaled allergen testing, nine underwent methacholine testing, and five subjects underwent both tests. Additionally, seven healthy controls underwent a mock challenge. Mixed-expired and end-expiratory carbon monoxide and end-expiratory nitric oxide levels were measured together with spirometry before, during (i.e. after each step of the inhalations), and after the challenges. Decreases in both end-expiratory (-14.4% in 9/11 subjects, p = 0.04) and mixed-expired (-7.5%, 9/11 subjects, p = 0.007) levels of carbon monoxide were noted during the immediate phase of the allergen challenge, with similar reductions after methacholine challenge, but levels were unaffected by repeated forced vital capacity exhalations alone. End-expiratory nitric oxide increased during the immediate phase of allergen challenge in 10/13 subjects (+10.8%, p = 0.05), but decreased after methacholine challenge in 14/14 subjects (-32.2%, p = 0.00009). Bronchospasm negatively modulates exhaled carbon monoxide and nitric oxide, but the inflammatory stimulus of allergen exposure increases exhaled nitric oxide. Measurements of exhaled monoxides may need to be referenced to the FEV1.

Original languageEnglish (US)
Article number47104
JournalJournal of Breath Research
Volume4
Issue number4
DOIs
StatePublished - Dec 2010

Fingerprint

Allergens
Carbon Monoxide
Nitric Oxide
Asthma
Methacholine Chloride
Exhalation
Bronchial Spasm
Spirometry
Vital Capacity
Inhalation
Gases
Inflammation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Sethi, J. M., White, A. M., Patel, S. A., DiNella, J. V., Calhoun, W., & Choi, A. M. K. (2010). Bronchoprovocation testing in asthma: Effect on exhaled monoxides. Journal of Breath Research, 4(4), [47104]. https://doi.org/10.1088/1752-7155/4/4/047104

Bronchoprovocation testing in asthma : Effect on exhaled monoxides. / Sethi, Jigme M.; White, Anna M.; Patel, Sanjay A.; DiNella, Jeannine V.; Calhoun, William; Choi, Augustine M K.

In: Journal of Breath Research, Vol. 4, No. 4, 47104, 12.2010.

Research output: Contribution to journalArticle

Sethi, Jigme M. ; White, Anna M. ; Patel, Sanjay A. ; DiNella, Jeannine V. ; Calhoun, William ; Choi, Augustine M K. / Bronchoprovocation testing in asthma : Effect on exhaled monoxides. In: Journal of Breath Research. 2010 ; Vol. 4, No. 4.
@article{af183f8f7f2540f492a748f19c317e55,
title = "Bronchoprovocation testing in asthma: Effect on exhaled monoxides",
abstract = "Exhaled carbon monoxide and nitric oxide reflect allergic inflammation in asthma and have clinical utility for monitoring disease severity. The effects of allergen challenge and of inflammatory versus non-inflammatory bronchoconstrictive stimuli on the exhalation kinetics of these gases are unclear. The aim of this study is to compare and contrast the effects of methacholine and allergen challenges on the exhaled levels of carbon monoxide and nitric oxide in a cohort of adult subjects with atopic asthma. Eight subjects underwent inhaled allergen testing, nine underwent methacholine testing, and five subjects underwent both tests. Additionally, seven healthy controls underwent a mock challenge. Mixed-expired and end-expiratory carbon monoxide and end-expiratory nitric oxide levels were measured together with spirometry before, during (i.e. after each step of the inhalations), and after the challenges. Decreases in both end-expiratory (-14.4{\%} in 9/11 subjects, p = 0.04) and mixed-expired (-7.5{\%}, 9/11 subjects, p = 0.007) levels of carbon monoxide were noted during the immediate phase of the allergen challenge, with similar reductions after methacholine challenge, but levels were unaffected by repeated forced vital capacity exhalations alone. End-expiratory nitric oxide increased during the immediate phase of allergen challenge in 10/13 subjects (+10.8{\%}, p = 0.05), but decreased after methacholine challenge in 14/14 subjects (-32.2{\%}, p = 0.00009). Bronchospasm negatively modulates exhaled carbon monoxide and nitric oxide, but the inflammatory stimulus of allergen exposure increases exhaled nitric oxide. Measurements of exhaled monoxides may need to be referenced to the FEV1.",
author = "Sethi, {Jigme M.} and White, {Anna M.} and Patel, {Sanjay A.} and DiNella, {Jeannine V.} and William Calhoun and Choi, {Augustine M K}",
year = "2010",
month = "12",
doi = "10.1088/1752-7155/4/4/047104",
language = "English (US)",
volume = "4",
journal = "Journal of Breath Research",
issn = "1752-7155",
publisher = "IOP Publishing Ltd.",
number = "4",

}

TY - JOUR

T1 - Bronchoprovocation testing in asthma

T2 - Effect on exhaled monoxides

AU - Sethi, Jigme M.

AU - White, Anna M.

AU - Patel, Sanjay A.

AU - DiNella, Jeannine V.

AU - Calhoun, William

AU - Choi, Augustine M K

PY - 2010/12

Y1 - 2010/12

N2 - Exhaled carbon monoxide and nitric oxide reflect allergic inflammation in asthma and have clinical utility for monitoring disease severity. The effects of allergen challenge and of inflammatory versus non-inflammatory bronchoconstrictive stimuli on the exhalation kinetics of these gases are unclear. The aim of this study is to compare and contrast the effects of methacholine and allergen challenges on the exhaled levels of carbon monoxide and nitric oxide in a cohort of adult subjects with atopic asthma. Eight subjects underwent inhaled allergen testing, nine underwent methacholine testing, and five subjects underwent both tests. Additionally, seven healthy controls underwent a mock challenge. Mixed-expired and end-expiratory carbon monoxide and end-expiratory nitric oxide levels were measured together with spirometry before, during (i.e. after each step of the inhalations), and after the challenges. Decreases in both end-expiratory (-14.4% in 9/11 subjects, p = 0.04) and mixed-expired (-7.5%, 9/11 subjects, p = 0.007) levels of carbon monoxide were noted during the immediate phase of the allergen challenge, with similar reductions after methacholine challenge, but levels were unaffected by repeated forced vital capacity exhalations alone. End-expiratory nitric oxide increased during the immediate phase of allergen challenge in 10/13 subjects (+10.8%, p = 0.05), but decreased after methacholine challenge in 14/14 subjects (-32.2%, p = 0.00009). Bronchospasm negatively modulates exhaled carbon monoxide and nitric oxide, but the inflammatory stimulus of allergen exposure increases exhaled nitric oxide. Measurements of exhaled monoxides may need to be referenced to the FEV1.

AB - Exhaled carbon monoxide and nitric oxide reflect allergic inflammation in asthma and have clinical utility for monitoring disease severity. The effects of allergen challenge and of inflammatory versus non-inflammatory bronchoconstrictive stimuli on the exhalation kinetics of these gases are unclear. The aim of this study is to compare and contrast the effects of methacholine and allergen challenges on the exhaled levels of carbon monoxide and nitric oxide in a cohort of adult subjects with atopic asthma. Eight subjects underwent inhaled allergen testing, nine underwent methacholine testing, and five subjects underwent both tests. Additionally, seven healthy controls underwent a mock challenge. Mixed-expired and end-expiratory carbon monoxide and end-expiratory nitric oxide levels were measured together with spirometry before, during (i.e. after each step of the inhalations), and after the challenges. Decreases in both end-expiratory (-14.4% in 9/11 subjects, p = 0.04) and mixed-expired (-7.5%, 9/11 subjects, p = 0.007) levels of carbon monoxide were noted during the immediate phase of the allergen challenge, with similar reductions after methacholine challenge, but levels were unaffected by repeated forced vital capacity exhalations alone. End-expiratory nitric oxide increased during the immediate phase of allergen challenge in 10/13 subjects (+10.8%, p = 0.05), but decreased after methacholine challenge in 14/14 subjects (-32.2%, p = 0.00009). Bronchospasm negatively modulates exhaled carbon monoxide and nitric oxide, but the inflammatory stimulus of allergen exposure increases exhaled nitric oxide. Measurements of exhaled monoxides may need to be referenced to the FEV1.

UR - http://www.scopus.com/inward/record.url?scp=78649846499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649846499&partnerID=8YFLogxK

U2 - 10.1088/1752-7155/4/4/047104

DO - 10.1088/1752-7155/4/4/047104

M3 - Article

VL - 4

JO - Journal of Breath Research

JF - Journal of Breath Research

SN - 1752-7155

IS - 4

M1 - 47104

ER -